Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Morito, Daisuke ^a   Nishikawa, Kouki ^b   Hoseki, Jun ^c,d   Kitamura, Akira ^e   Kotani, Yuri ^a   Kiso, Kazumi ^a   Kinjo, Masataka ^e   Fujiyoshi, Yoshinori ^b   Nagata, Kazuhiro ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; RNF213 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HEK293 CELL LINE; HUMAN; HYDROLYSIS; METABOLISM; MOYAMOYA DISEASE; PATHOLOGY; PROTEIN CONFORMATION;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; HYDROLYSIS; MOYAMOYA DISEASE; PROTEIN CONFORMATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84906766180     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04442     Document Type: Article

References (45)

1. Takeuchi, K. & Shimizu, K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9, 37-43 (1957).
2. Kuroda, S. & Houkin, K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7, 1056-1066, http://dx.doi.org/10.1016/S1474-4422(08)70240-0 (2008).
3. Scott, R. M. & Smith, E. R. Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 360, 1226-1237, http://dx.doi.org/10.1056/NEJMra0804622 (2009).
4. Suzuki, J. & Takaku, A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 20, 288-299 (1969).
5. Fukui, M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin. Neurol. Neurosurg. 99 Suppl 2, S238-240 (1997).
6. Yonekawa, Y., Ogata, N., Kaku, Y., Taub, E. & Imhof, H. G. Moyamoya disease in Europe, past and present status. Clin. Neurol. Neurosurg. 99 Suppl 2, S58-60 (1997).
7. Wakai, K. et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin. Neurol. Neurosurg. 99 Suppl 2, S1-5 (1997).
8. Kuriyama, S. et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39, 42-47, http://dx.doi.org/10.1161/STROKEAHA.107.490714 (2008).
9. Baba, T., Houkin, K. & Kuroda, S. Novel epidemiological features of moyamoya disease. J. Neurol. Neurosurg. Psychiatry 79, 900-904, http://dx.doi.org/10.1136/jnnp.2007.130666 (2008).
10. Yamauchi, T., Houkin, K., Tada, M. & Abe, H. Familial occurrence of moyamoya disease. Clin. Neurol. Neurosurg. 99 Suppl 2, S162-167 (1997).
11. Mineharu, Y. et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J. Neurol. Neurosurg. Psychiatry 77, 1025-1029, http://dx.doi.org/10.1136/jnnp.2006.096040 (2006).
12. Yamauchi, T. et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31, 930-935 (2000).
13. Houkin, K. et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol. Med. Chir. (Tokyo). 52, 267-277 (2012).
14. Liu, W. et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6, e22542, http://dx.doi.org/10.1371/journal.pone.0022542 (2011).
15. Kamada, F. et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J. Hum. Genet. 56, 34-40, http://dx.doi.org/10.1038/jhg.2010.132 (2011).
16. Miyatake, S. et al. Homozygous c.14576G > A variant of RNF213 predicts earlyonset and severe form of moyamoya disease. Neurology 78, 803-810, http://dx.doi.org/10.1212/WNL.0b013e318249f71f (2012).
17. Koizumi, A. et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med, http://dx.doi.org/10.1007/s12199-012-0299-1 (2012).
18. Miyatake, S. et al. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G > A variant in RNF213 showed varying clinical course and severity. J. Hum. Genet. 57, 804-806, http://dx.doi.org/10.1038/jhg.2012.105 (2012).
19. Wu, Z. et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One 7, e48179, http://dx.doi.org/10.1371/journal.pone.0048179 (2012).
20. Leipe, D. D., Wolf, Y. I., Koonin, E. V. & Aravind, L. Classification and evolution of P-loop GTPases and related ATPases. J. Mol. Biol. 317, 41-72, http://dx.doi.org/ 10.1006/jmbi.2001.5378 (2002).
21. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479, http://dx.doi.org/10.1146/annurev.biochem.67.1.425 (1998).
22. Joazeiro, C. A. &Weissman, A. M. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102, 549-552 (2000).
23. Ogura, T. & Wilkinson, A. J. AAA1 superfamily ATPases: common structure - diverse function. Genes Cells 6, 575-597 (2001).
24. Hanson, P. I.&Whiteheart, S. W. AAA1 proteins: have engine, will work. Nat Rev Mol Cell Biol 6, 519-529, http://dx.doi.org/10.1038/nrm1684 (2005).
25. Glover, J. R. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82 (1998).
26. Lee, S. et al. The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell 115, 229-240 (2003).
27. Cashikar, A. G. et al. Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. Mol. Cell 9, 751-760 (2002).
28. Oguchi, Y. et al. A tightly regulated molecular toggle controls AAA+ disaggregase. Nat Struct Mol Biol 19, 1338-1346, http://dx.doi.org/10.1038/nsmb.2441 (2012).
29. Seyffer, F. et al. Hsp70 proteins bind Hsp100 regulatory M domains to activate AAA+ disaggregase at aggregate surfaces. Nat Struct Mol Biol 19, 1347-1355, http://dx.doi.org/10.1038/nsmb.2442 (2012).
30. Stark, H. et al. The 70S Escherichia coli ribosome at 23 A resolution: fitting the ribosomal RNA. Structure 3, 815-821 (1995).
31. Lippincott-Schwartz, J., Snapp, E. & Kenworthy, A. Studying protein dynamics in living cells. Nat Rev Mol Cell Biol 2, 444-456, http://dx.doi.org/10.1038/35073068 (2001).
32. Pack, C., Saito, K., Tamura, M. & Kinjo, M. Microenvironment and effect of energy depletion in the nucleus analyzed by mobility of multiple oligomeric EGFPs. Biophys. J. 91, 3921-3936, http://dx.doi.org/10.1529/biophysj.105.079467 (2006).
33. Parsell, D. A., Kowal, A. S. & Lindquist, S. Saccharomyces cerevisiae Hsp104 protein. Purification and characterization of ATP-induced structural changes. J. Biol. Chem. 269, 4480-4487 (1994).
34. Hartman, J. J. & Vale, R. D. Microtubule disassembly by ATP-dependent oligomerization of the AAA enzyme katanin. Science 286, 782-785 (1999).
35. Wang, Q., Song, C. & Li, C. C. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem. Biophys. Res. Commun. 300, 253-260 (2003).
36. Mogk, A. et al. Roles of individual domains and conserved motifs of the AAA+ chaperone ClpB in oligomerization, ATP hydrolysis, and chaperone activity. J. Biol. Chem. 278, 17615-17624, http://dx.doi.org/10.1074/jbc.M209686200 (2003).
37. Neuwald, A. F., Aravind, L., Spouge, J. L. & Koonin, E. V. AAA1: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27-43 (1999).
38. Lupas, A. N. & Martin, J. AAA proteins. Curr. Opin. Struct. Biol. 12, 746-753 (2002).
39. Shestakova, A. et al. Assembly of the AAA ATPase Vps4 on ESCRT-III. Mol. Biol. Cell 21, 1059-1071, http://dx.doi.org/10.1091/mbc.E09-07-0572 (2010).
40. Azmi, I. et al. Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1. J. Cell Biol. 172, 705-717, http://dx.doi.org/10.1083/jcb.200508166 (2006).
41. Kirstein, J. et al. Adaptor protein controlled oligomerization activates the AAA+ protein ClpC. EMBO J. 25, 1481-1491, http://dx.doi.org/10.1038/sj.emboj. 7601042 (2006).
42. Yamaguchi, A. et al. Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species. Nucleic Acids Res 31, 463-468 (2003).
43. Koradi, R., Billeter, M. & Wuthrich, K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-55, 29-32 (1996).
44. Chan, K. M., Delfert, D. & Junger, K. D. A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal. Biochem. 157, 375-380 (1986).
45. Morito, D. et al. Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol. Biol. Cell 19, 1328-1336, http://dx.doi.org/10.1091/mbc.E07-06-0601 (2008).